- Home
- MFH vs ANGO Comparison
MFH vs ANGO Comparison
Compare MFH & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFH
- ANGO
- Stock Information
- Founded
- MFH 2011
- ANGO 1988
- Country
- MFH United States
- ANGO United States
- Employees
- MFH N/A
- ANGO N/A
- Industry
- MFH Finance: Consumer Services
- ANGO Medical/Dental Instruments
- Sector
- MFH Finance
- ANGO Health Care
- Exchange
- MFH Nasdaq
- ANGO Nasdaq
- Market Cap
- MFH 382.7M
- ANGO 439.5M
- IPO Year
- MFH N/A
- ANGO 2004
- Fundamental
- Price
- MFH $5.85
- ANGO $9.52
- Analyst Decision
- MFH
- ANGO Strong Buy
- Analyst Count
- MFH 0
- ANGO 2
- Target Price
- MFH N/A
- ANGO $14.00
- AVG Volume (30 Days)
- MFH 64.6K
- ANGO 674.1K
- Earning Date
- MFH 04-25-2025
- ANGO 04-02-2025
- Dividend Yield
- MFH N/A
- ANGO N/A
- EPS Growth
- MFH N/A
- ANGO N/A
- EPS
- MFH N/A
- ANGO N/A
- Revenue
- MFH $716,863.00
- ANGO $283,320,000.00
- Revenue This Year
- MFH N/A
- ANGO N/A
- Revenue Next Year
- MFH N/A
- ANGO $6.35
- P/E Ratio
- MFH N/A
- ANGO N/A
- Revenue Growth
- MFH 119.50
- ANGO N/A
- 52 Week Low
- MFH $1.03
- ANGO $5.47
- 52 Week High
- MFH $8.86
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- MFH 54.51
- ANGO 48.91
- Support Level
- MFH $5.10
- ANGO $9.26
- Resistance Level
- MFH $5.78
- ANGO $9.94
- Average True Range (ATR)
- MFH 0.64
- ANGO 0.65
- MACD
- MFH 0.08
- ANGO 0.01
- Stochastic Oscillator
- MFH 81.48
- ANGO 26.17
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.